Introduction And Objectives: Decoding the genetic basis of coronary artery disease (CAD) through an intermediate phenotype - coronary calcification - can help us to better understand this deadly disease and enable the creation of better therapeutic strategies. This work aims to assess the relationship between a set of single nucleotide polymorphisms (SNPs) previously associated with CAD and coronary artery calcium (CAC) score in a Portuguese asymptomatic population.
Methods: A prospective study was conducted in a cohort of 1284 subjects (aged 59.3±8.9 years, 73.6% males) without CAD. CAC score was performed using cardiac computed tomography. Thirty-three SNPs were genotyped using TaqMan real-time PCR. Anthropometric, conventional, and biochemical risk factors were evaluated. Bivariate and multivariate regression analysis estimated variables associated with the CAC score.
Results: PHACTR1 rs1332844 C>T, a downstream regulator of the endothelin-1 gene, showed a significant association with CAC score (p=0.015), together with CDKN2B-AS1 variants rs4977574 A>G (p=0.002) and rs1333049 G>C (p=0.010) in the 9p21.3 locus. MTHFD1L rs6922269 G>A variant encoding a mitochondrial enzyme responsible for homocysteine remethylating showed protection against artery calcification (p=0.013). After multivariate logistic regression, PHACTR1 rs1332844 (CT+TT) (OR=1.478;p=0.009) and CDKN2B-AS1 rs4977574 (GG) (OR=1.479;p=0.002) remained in the equation as independently associated with arterial calcification. MTHFD1L rs6922269 (AA) also remained associated with a lower CAC score (OR=0.558;p=0.027).
Conclusion: This study showed that three genetic variants previously linked with CAD are associated with CAC in asymptomatic populations. Understanding these genetic factors, combined with conventional risk factors, could guide lifestyle changes or pharmacologic interventions to mitigate CAD risk before the disease becomes clinical.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.repc.2025.01.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Impact of Zero Coronary Artery Calcium Scoring on Downstream Cardiac Testing and Cardiac Outcomes Compared With No Testing.
CJC Open
February 2025
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Background: The impact of coronary artery calcium (CAC) scoring on downstream resource utilisation and outcomes remains unclear, especially in those with zero CAC.
Methods: Consecutive CAC scores from two academic hospitals in Toronto, Ontario, were linked to population-based databases. Subjects with zero CAC without previous cardiovascular disease were propensity score matched with a non-CAC-tested control group for age, sex, cardiovascular risk factors, and comorbidities.
Inflammatory markers and calcification of coronary arteries, aorta and cardiac valves: Findings from the atherosclerosis risk in communities study.
Am J Prev Cardiol
March 2025
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Background: Inflammation plays an important role in the pathophysiology of atherosclerosis. However, inflammatory biomarkers have only been weakly associated with coronary artery calcium (CAC), a representative measure of subclinical atherosclerosis. Moreover, few studies explored extra-coronary calcium (ECC) in this context.
View Article and Find Full Text PDFClinical Significance of Diabetes in Asymptomatic Individuals with Zero Coronary Artery Calcium Score.
Am J Cardiol
March 2025
Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Electronic address:
The clinical significance of diabetes mellitus (DM) on the cardiovascular disease in the zero coronary artery calcium (CAC) group is not well studied. This study investigated the impact of DM in an asymptomatic population with zero CAC scores. Overall, 9269 adults who received coronary computed tomography angiography (CCTA) scans for coronary disease evaluation during a general medical checkup were initially selected.
View Article and Find Full Text PDFUnraveling the genetic basis of subclinical atherosclerosis: Early genetic detection can improve cardiovascular prevention.
Rev Port Cardiol
March 2025
NOVA Medical School, Faculdade de Ciências Médicas, Campo dos Mártires da Pátria 130, 1169-056 Lisboa, Portugal.
Introduction And Objectives: Decoding the genetic basis of coronary artery disease (CAD) through an intermediate phenotype - coronary calcification - can help us to better understand this deadly disease and enable the creation of better therapeutic strategies. This work aims to assess the relationship between a set of single nucleotide polymorphisms (SNPs) previously associated with CAD and coronary artery calcium (CAC) score in a Portuguese asymptomatic population.
Methods: A prospective study was conducted in a cohort of 1284 subjects (aged 59.
Association of lipoprotein(a) and coronary artery calcium with atherosclerotic cardiovascular disease.
J Clin Lipidol
February 2025
Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea (Dr Kang); Department of Clinical Research Design & Evaluation, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea (Dr Kang).
Background: A combined evaluation of the associations of lipoprotein(a) (LP[a]) and coronary artery calcium score (CACS) with atherosclerotic cardiovascular disease (ASCVD) has not been conducted in the Asian population.
Objective: We explored whether elevated LP(a) levels and CACS are independently and jointly associated with ASCVD.
Methods: This cross-sectional study included 44,354 participants (mean age 40.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!